A novel protein signature from plasma extracellular vesicles for non-invasive differential diagnosis of idiopathic pulmonary fibrosis
Sitaramaraju Adduri(The University of Texas Health Science Center at Tyler), Nagarjun V. Konduru(The University of Texas Health Science Center at Tyler), Daniela Nicastro(Southwestern Medical Center), Karen Velasco Alzate(The University of Texas Health Science Center at Tyler), Noboru Hattori(Hiroshima University), Iván O. Rosas(Brigham and Women's Hospital), Fernando Poli de Frias(Brigham and Women's Hospital), Hiroshi Iwamoto(Hiroshima University), Sergio Poli(Brigham and Women's Hospital), Kevin F. Gibson(University of Pittsburgh), Daniel J. Kass(University of Pittsburgh), Jeffrey W. Miller(Harvard University), Ravikiran Vasireddy(The University of Texas Health Science Center at Tyler), Yasushi Horimasu(Hiroshima University), Lynette M. Sholl(Brigham and Women's Hospital), Kai Cai(The University of Texas Southwestern Medical Center), David A. Schwartz(Perinatal Institute), Yingze Zhang(Hebei Medical University), Anoop K. Pal(Cambridge Systematics (United States)), Lily Li(University of Colorado Denver), Sujith V. Cherian(The University of Texas Health Science Center)
Cited by 0
Related Papers
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
|Science Advances|2020|1.5k
Toll-like Receptor 4 Polymorphisms and Atherogenesis
|New England Journal of Medicine|2002|1k
Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis
|Nature Communications|2020|780
Muc5b is required for airway defence
|Nature|2013|777